Search Results - "Food and Drug Administration"

Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients by Annalisa Noce, Maria Albanese, Giulia Marrone, Manuela Di Lauro, Anna Pietroboni Zaitseva, Daniela Palazzetti, Cristina Guerriero, Agostino Paolino, Giuseppa Pizzenti, Francesca Di Daniele, Annalisa Romani, Cartesio D'Agostini, Andrea Magrini, Nicola Biagio Mercuri, Nicola Di Daniele

Connect to this object online.

The effect of variation of tetrahydropentagamavunon-0 concentration in lotion and emulgel formula toward acute dermal irritation study by Ritmaleni, Dina Suci Susilo Putri, Tia Wulandari, Abdul Karim Zulkarnain, Mimiek Murrukmihadi

Connect to this object online.

Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis by Mohd Imran, Shah Alam Khan, Mohammed Kanan Alshammari, Ashwaq Muiedh Alqahtani, Turkiah Abdullah Alanazi, Mehnaz Kamal, Talha Jawaid, Mohammed M. Ghoneim, Sultan Alshehri, Faiyaz Shakeel

Connect to this object online.

Policy maker and provider knowledge and attitudes regarding the provision of emergency contraceptive pills within Lao PDR by Hansana Visanou, Phongsavan Keokedthong, Sychareun Vanphanom, Phengsavanh Alongkone

Connect to this object online.

Anti-Inflammatory Effects of Dimethyl Fumarate in Microglia via an Autophagy Dependent Pathway by Young-Sun Lee, Young-Sun Lee, Deepak Prasad Gupta, Sung Hee Park, Hyun-Jeong Yang, Gyun Jee Song, Gyun Jee Song

Connect to this object online.

Novel pharmaceutical dosage forms of analgesics by Đekić Ljiljana, Primorac Marija

Connect to this object online.

Capecitabine-associated gastrointestinal ulceration, haemorrhage, and obstruction: a pharmacovigilance analysis based on the FAERS by Yuwei Wang, Long Meng, Xiao Liu

Connect to this object online.

Developing Smokeless Tobacco Prevention Messaging for At-Risk Youth: Early Lessons from ?The Real Cost? Smokeless Campaign by Matthew W. Walker, Sarah A. Evans, Cameron Wimpy, Amanda T. Berger, Alexandria A. Smith

Connect to this object online.

Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future by Ga Won Jeon

Connect to this object online.

Guidance on the Conduct of Clinical Research within OECD Countries during the Early Stages of the COVID-19 Pandemic: A Systematic Review by Renu Bhutkar, Jack C. Collins, Claire L. O'Reilly, Sarira El-Den

Connect to this object online.

A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system by Zhihong Fang, Zhiqiang Xu, Wei Zhu, Mingming Yu, Chunmei Ji

Connect to this object online.

Postmarket safety communications on drugs approved in Japan: A 25‐year analysis by Yusuke Tanaka, Mototsugu Tanaka, Haruna Miyazawa, Ryohei Terashima, Makoto Miyazawa, Mutsuhiro Ikuma, Yoshihiko Tomita

Connect to this object online.

Correcting India's Chronic Shortage of Drug Inspectors to Ensure the Production and Distribution of Safe, High-Quality Medicines by Abhay B. Kadam, Karen Maigetter, Roger Jeffery, Nerges F. Mistry, Mitchell G. Weiss, Allyson M. Pollock

Connect to this object online.

Translatability of in vitro potency to clinical efficacious exposure: A retrospective analysis of FDA‐approved targeted small molecule oncology drugs by Naoki Kotani, Kiyomi Ito

Connect to this object online.

Menthol cigarettes and the public health standard: a systematic review by Andrea C. Villanti, Lauren K. Collins, Raymond S. Niaura, Stacey Y. Gagosian, David B. Abrams

Connect to this object online.

Analysis of reported adverse liver reactions associated with drugs used to treat patients with coronavirus disease 2019 by Nayara Aparecida de Oliveira-Silva, Albert Figueras, Daniela Oliveira de Melo

Connect to this object online.

Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries by Mackenzie Mills, Daniel Michaeli, Aurelio Miracolo, Panos Kanavos

Connect to this object online.

Clinical trials in Latin America: implications for the sustainability and safety of pharmaceutical markets and the wellbeing of research subjects by Núria Homedes, Antonio Ugalde

Connect to this object online.

Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer's disease: patient outcomes, healthcare costs, and drug development by Rouen Brockmann, Joanna Nixon, Bryan L. Love, Ismaeel Yunusa

Connect to this object online.

Educational intervention can improve appropriateness of acid suppression therapy in hospitalized geriatric patients by Sankalp Dwivedi, Jaya Edukulla, Sindhu Rajendra, Sandesh Murali, Serge A. Sorser, Marc S. Piper, Michael Piper, Bradley J. Warren, Harsha Ramchandani

Connect to this object online.